ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 681972 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 681972; 2) Community: the network communities that were significantly associated with the response to NSC 681972; 3) Molecule: the relationships between components within communities and NSC 681972; 4) MDR: the compounds that were significantly associated with the NSC 681972.

NSC Compound Enrichment Correlation
NSC 706031 Null 0.0212053315848709 0.28768997
NSC 711074 Null 0.0212053315848709 0.64926102
NSC 713750 Null 0.0212053315848709 0.0045029099
NSC 723001 Diethyl-N[4-(3-thienylquinoxalyn-2-yl)oxiphenylacetyl]-L-glu tamate 0.0212053315848709 -0.31020504
NSC 724784 (1S,4R,5R,8R,12R,13S)-1,5-dimethyl-9-methylene-11,14,15,16-t etraoxatetracyclo[10.3.1.04,13.08,13]hexadec-10-yl]oxy}-3-he xenyl)oxy]-1,5,-dimethyl-9-methylene-11,14,15,16-tetraoxatet racyclo[10.3.1.0 0.0212053315848709 0.26592317
NSC 763587 Null 0.0212053315848709 0.28799021
NSC 174121 Methotrexate Derivative 0.0212053315848711 0.35291046
NSC 324979 Copper, chloro[hexahydro-1H-azepine-1-carbothioic acid [1-(2-pyridinyl)ethylidene]hydrazidato]-, (SP-4-3)- 0.0212053315848711 0.19978504
NSC 39351 Null 0.0212053315848711 0.23779927
NSC 647638 1,2-Dioxin-3-acetic acid, 3,6-dihydro-6-methoxy-6-(14,16- octadecadienyl)-, methyl ester, [3.alpha.,6.alpha.,6(14E,16E)]-(+)- (9CI) 0.0212053315848711 0.15416619
Total:105  Current:53    [First] [Prev] [Next] [Last]